INVO Fertility, Inc. (IVF) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
IVF Revenue Growth
IVF Revenue Analysis (2013–2024)
As of May 9, 2026, INVO Fertility, Inc. (IVF) generated trailing twelve-month (TTM) revenue of $6.9 million, reflecting exceptional growth of +22.6% year-over-year. The most recent quarter (Q3 2025) recorded $1.8 million in revenue, down 5.7% sequentially.
Looking at the longer-term picture, IVF's 5-year compound annual growth rate (CAGR) stands at +34.6%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $6.5 million in 2024, representing a new all-time high.
When compared to Healthcare sector peers including NTRA (+36.6% YoY), PGNY (+6.6% YoY), and INMD (-4.5% YoY), IVF has underperformed the peer group in terms of revenue growth. Compare IVF vs NTRA →
IVF Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| IVFCurrent | $7M | +22.6% | +34.6% | -124.4% | |
 NTRA | $2.3B | +36.6% | +42.6% | -13.4% | |
 PGNY | $1.3B | +6.6% | +30.2% | 6.6% | |
 INMD | $370M | -4.5% | +12.4% | 23.0% | |
 MARA | $907M | - | - | -90.6% | |
 HOLX | $4.1B | +2.2% | +1.7% | 17.4% |
IVF Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $6.5M | +116.3% | $2.9M | 44.0% | $-8,125,496 | -124.4% |
| 2023 | $3.0M | +267.4% | $1.1M | 36.0% | $-6,767,155 | -224.0% |
| 2022 | $822K | -80.2% | $-28,574 | -3.5% | $-10,626,481 | -1292.5% |
| 2021 | $4.2M | +301.1% | $4.0M | 96.5% | $-5,216,524 | -125.4% |
| 2020 | $1.0M | -29.9% | $949K | 91.4% | $-5,514,966 | -531.7% |
| 2019 | $1.5M | +199.4% | $1.3M | 90.6% | $-1,788,092 | -120.8% |
| 2018 | $494K | +75.2% | $404K | 81.7% | $-2,634,060 | -532.8% |
| 2017 | $282K | +454.3% | $230K | 81.6% | $-640,421 | -227.0% |
| 2016 | $51K | +335.5% | $36K | 70.3% | $-2,110,414 | -4146.1% |
| 2015 | $12K | -29.5% | $4K | 33.2% | $-595,074 | -5090.9% |
See IVF's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs IVF Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare IVF vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonIVF — Frequently Asked Questions
Quick answers to the most common questions about buying IVF stock.
Is IVF's revenue growth accelerating or slowing?
IVF revenue is accelerating at +22.6% year-over-year, exceeding the 5-year CAGR of +34.6%. TTM revenue reached $7M. Growth momentum has increased versus prior periods.
What is IVF's long-term revenue growth rate?
INVO Fertility, Inc.'s 5-year revenue CAGR of +34.6% reflects the sustained expansion pattern. Current YoY growth of +22.6% is above this long-term average.
How is IVF's revenue distributed by segment?
IVF reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.